Leadership team
United Kingdom
Norman de Villiers
C.E.O.
Norman is the driving force behind Medi-stats and Medtech development for Pharmacy application. His experience in pharmacy, health and the application of new technology puts him at the cutting-edge of heart health research and development within the pharmaceutical arena, where he encourages the use of the latest cardiovascular, Spiromitory and haematology technology to advance primary healthcare through pharmacy. Norman is highly skilled in business planning and management and has completed an MPhil commissioned by the MoD, investigating how combat-related traumatic injuries and amputations affect cardiovascular risk. He is co-author of a published systematic review on this topic.
Michael Close
Director of Logistics and Pharma
As Director of Logistics and Pharma, Michael’s 25 years’ experience gives him a robust Biomedical and Big Pharma background, and a strong track-record in commercialising novel therapeutics and diagnostics to market by developing successful partnerships, applying expertise in commercial and regulatory activities, licensing, registration and approval, pricing and reimbursement and advancing market access. Michael is the MHRA approved Responsible Person of LogixX Pharma Ltd, and serves on the board of a number of companies.
Norbert Roberts
Operations and Design
With over 30 years’ experience in the design industry, Norbert is responsible for the evolving design of the Medi-stats health portal, which he continues to develop as a leading hypertensive platform for patients. Norbert’s focus is on creating an engaging user journey through clean design that takes complex diagnostics results and communicates them simply and clearly. This ensures our patients experience an immersive platform that engages them with their health and ultimately improves outcomes.
United States
David Seftel
Chief Medical Advisor
Dr David Seftel is an award-winning and renowned international expert on Bioscience technology. David co-founded Enable Biosciences, which has developed, validated and published the performance of its patent-pending, rapid, multiplexable, early disease detection technology in top peer-reviewed medical journals, including the Proceedings of the National Academy of Sciences. Enable Biosciences has received numerous awards; most recently, Enable’s diabetes test was adjudicated as the best in the world in a blinded shoot-out of 60 competing labs at the Immunology of Diabetes Society’s annual Antibody Standardization competition (IASP) in London, England.
Australia & New Zealand
Andrew Holmes
Director of Global Operations
Charl de Villiers
Project Manager
Digital development team
Alexandru Andrascu
Project Manager
Radu Andrascu
Project Lead
Eugen Andrasescu
Lead Developer